{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:09:15Z","timestamp":1788480555641,"version":"build-2803163510"},"reference-count":89,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Arrhythmogenic cardiomyopathy (ACM) is an inheritable heart muscle disease characterised pathologically by fibrofatty myocardial replacement and clinically by ventricular arrhythmias (VAs) and sudden cardiac death (SCD). Although, in its original description, the disease was believed to predominantly involve the right ventricle, biventricular and left-dominant variants, in which the myocardial lesions affect in parallel or even mostly the left ventricle, are nowadays commonly observed. The clinical management of these patients has two main purposes: the prevention of SCD and the control of arrhythmic and heart failure (HF) events. An implantable cardioverter defibrillator (ICD) is the only proven lifesaving treatment, despite significant morbidity because of device-related complications and inappropriate shocks. Selection of patients who can benefit the most from ICD therapy is one of the most challenging issues in clinical practice. Risk stratification in ACM patients is mostly based on arrhythmic burden and ventricular dysfunction severity, although other clinical features resulting from electrocardiogram and imaging modalities such as cardiac magnetic resonance may have a role. Medical therapy is crucial for treatment of VAs and the prevention of negative ventricular remodelling. In this regard, the efficacy of novel anti-HF molecules and drugs acting on the inflammatory pathway in patients with ACM is, to date, unknown. Catheter ablation represents an effective strategy to treat ventricular tachycardia relapses and recurrent ICD shocks. The present review will address the current strategies for prevention of SCD and treatment of VAs and HF in patients with ACM.<\/jats:p>","DOI":"10.3390\/jcm10132750","type":"journal-article","created":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T13:02:10Z","timestamp":1624366930000},"page":"2750","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Arrhythmogenic Cardiomyopathy\u2014Current Treatment and Future Options"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8574-9421","authenticated-orcid":false,"given":"Federico","family":"Migliore","sequence":"first","affiliation":[{"name":"Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padova, Via Giustiniani 2, 35128 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Mattesi","sequence":"additional","affiliation":[{"name":"Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padova, Via Giustiniani 2, 35128 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3578-0583","authenticated-orcid":false,"given":"Alessandro","family":"Zorzi","sequence":"additional","affiliation":[{"name":"Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padova, Via Giustiniani 2, 35128 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Bauce","sequence":"additional","affiliation":[{"name":"Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padova, Via Giustiniani 2, 35128 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Rigato","sequence":"additional","affiliation":[{"name":"Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padova, Via Giustiniani 2, 35128 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Corrado","sequence":"additional","affiliation":[{"name":"Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padova, Via Giustiniani 2, 35128 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7842-6202","authenticated-orcid":false,"given":"Alberto","family":"Cipriani","sequence":"additional","affiliation":[{"name":"Department of Cardiac, Thoracic and Vascular Sciences and Public Health, University of Padova, Via Giustiniani 2, 35128 Padova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,6,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1161\/CIRCRESAHA.117.309345","article-title":"Arrhythmogenic Cardiomyopathy","volume":"121","author":"Corrado","year":"2017","journal-title":"Circ. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.CIR.94.5.983","article-title":"Arrhythmogenic Right Ventricular Cardiomyopathy: Dysplasia, dystrophy, or myocarditis?","volume":"94","author":"Basso","year":"1996","journal-title":"Circulation"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1084\/jem.20090641","article-title":"Myocyte necrosis underlies progressive myocardial dystrophy in mouse dsg2-related arrhythmogenic right ventricular cardiomyopathy","volume":"206","author":"Pilichou","year":"2009","journal-title":"J. Exp. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S1054-8807(01)00067-9","article-title":"Arrhythmogenic right ventricular cardiomyopathy: An update","volume":"10","author":"Thiene","year":"2001","journal-title":"Cardiovasc. Pathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1016\/j.jacc.2008.09.019","article-title":"Left-Dominant Arrhythmogenic Cardiomyopathy","volume":"52","author":"Syrris","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1111\/jce.12222","article-title":"Mutation-Positive Arrhythmogenic Right Ventricular Dysplasia\/Cardiomyopathy: The Triangle of Dysplasia Displaced","volume":"24","author":"James","year":"2013","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1093\/eurheartj\/ehz669","article-title":"International Experts. Arrhythmogenic right ventricular cardiomyopathy: Evaluation of the current diagnostic criteria and differential diagnosis","volume":"41","author":"Corrado","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/S0140-6736(00)02379-5","article-title":"Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease)","volume":"355","author":"McKoy","year":"2000","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1086\/344208","article-title":"Mutation in Human Desmoplakin Domain Binding to Plakoglobin Causes a Dominant Form of Arrhythmogenic Right Ventricular Cardiomyopathy","volume":"71","author":"Rampazzo","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/ng1461","article-title":"Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy","volume":"36","author":"Gerull","year":"2004","journal-title":"Nat. Genet."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1161\/CIRCULATIONAHA.105.583674","article-title":"Mutations in Desmoglein-2 Gene Are Associated with Arrhythmogenic Right Ventricular Cardiomyopathy","volume":"113","author":"Pilichou","year":"2006","journal-title":"Circulation"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1086\/509122","article-title":"Arrhythmogenic Right Ventricular Dysplasia\/Cardiomyopathy Associated with Mutations in the Desmosomal Gene Desmocollin-2","volume":"79","author":"Syrris","year":"2006","journal-title":"Am. J. Hum. Genet."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/eurheartj\/ehs373","article-title":"Mutations in the area composita protein \u03b1T-catenin are associated with arrhythmogenic right ventricular cardiomyopathy","volume":"34","author":"Calore","year":"2013","journal-title":"Eur. Hear. J."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Mayosi, B.M., Fish, M., Shaboodien, G., Mastantuono, E., Kraus, S., Wieland, T., Kotta, M.-C., Chin, A., Laing, N., and Ntusi, N.B. (2017). Identification of Cadherin 2 (CDH2) Mutations in Arrhythmogenic Right Ventricular Cardiomyopathy. Circ. Cardiovasc. Genet., 10.","DOI":"10.1161\/CIRCGENETICS.116.001605"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1172\/JCI27751","article-title":"Suppression of canonical Wnt\/ -catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy","volume":"116","author":"Gras","year":"2006","journal-title":"J. Clin. Investig."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Mattesi, G., Zorzi, A., Corrado, D., and Cipriani, A. (2020). Natural History of Arrhythmogenic Cardiomyopathy. J. Clin. Med., 9.","DOI":"10.3390\/jcm9030878"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e003631","DOI":"10.1161\/CIRCEP.115.003631","article-title":"Relationship Between Arrhythmogenic Right Ventricular Cardiomyopathy and Brugada Syndrome","volume":"9","author":"Corrado","year":"2016","journal-title":"Circ. Arrhythmia Electrophysiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ajhg.2008.01.010","article-title":"Arrhythmogenic Right Ventricular Cardiomyopathy Type 5 Is a Fully Penetrant, Lethal Arrhythmic Disorder Caused by a Missense Mutation in the TMEM43 Gene","volume":"82","author":"Merner","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/eurheartj\/ehr451","article-title":"Mutations in the Lamin A\/C gene mimic arrhythmogenic right ventricular cardiomyopathy","volume":"33","author":"Quarta","year":"2011","journal-title":"Eur. Hear. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.hrthm.2009.07.041","article-title":"Severe cardiac phenotype with right ventricular predominance in a large cohort of patients with a single missense mutation in the DES gene","volume":"6","author":"Asimaki","year":"2009","journal-title":"Hear. Rhythm."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1161\/CIRCULATIONAHA.110.005405","article-title":"Genetic Variation in Titin in Arrhythmogenic Right Ventricular Cardiomyopathy\u2013Overlap Syndromes","volume":"124","author":"Taylor","year":"2011","journal-title":"Circulation"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/eurjhf\/hfs119","article-title":"Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: Evidence supporting the concept of arrhythmogenic cardiomyopathy","volume":"14","author":"Asimaki","year":"2012","journal-title":"Eur. J. Hear. Fail."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.cardiores.2004.10.005","article-title":"Regulatory mutations in transforming growth factor-?3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1","volume":"65","author":"Beffagna","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1161\/CIRCULATIONAHA.106.660241","article-title":"Clinical and Genetic Characterization of Families with Arrhythmogenic Right Ventricular Dysplasia\/Cardiomyopathy Provides Novel Insights Into Patterns of Disease Expression","volume":"115","author":"Syrris","year":"2007","journal-title":"Circulation"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/eurheartj\/ehu509","article-title":"Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia\/cardiomyopathy-associated mutation carriers","volume":"36","author":"Bhonsale","year":"2015","journal-title":"Eur. Hear. J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.jacc.2016.09.927","article-title":"Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies","volume":"68","author":"Cuenca","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.hrthm.2020.01.035","article-title":"Clinical characteristics and determinants of the phenotype in TMEM43 arrhythmogenic right ventricular cardiomyopathy type 5","volume":"17","author":"Dominguez","year":"2020","journal-title":"Hear. Rhythm."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jacep.2017.12.003","article-title":"Filamin C Truncation Mutations Are Associated with Arrhythmogenic Dilated Cardiomyopathy and Changes in the Cell\u2013Cell Adhesion Structures","volume":"4","author":"Begay","year":"2018","journal-title":"JACC Clin. Electrophysiol."},{"key":"ref_29","first-page":"326","article-title":"Dilated cardiomyopathy and arrhythmogenic left ventricular cardiomyopathy: A comprehensive genotype-imaging phenotype study","volume":"21","author":"Augusto","year":"2019","journal-title":"Eur. Hear. J. Cardiovasc. Imaging"},{"key":"ref_30","first-page":"378","article-title":"Myocardial fibrosis in arrhythmogenic cardiomyopathy: A genotype\u2013phenotype correlation study","volume":"21","author":"Carriel","year":"2019","journal-title":"Eur. Hear. J. Cardiovasc. Imaging"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Mattesi, G., Cipriani, A., Bauce, B., Rigato, I., Zorzi, A., and Corrado, D. (2021). Arrhythmogenic Left Ventricular Cardiomyopathy: Genotype-Phenotype Correlations and New Diagnostic Criteria. J. Clin. Med., 10.","DOI":"10.3390\/jcm10102212"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/jcp.53.5.382","article-title":"No detection of enteroviral genome in the myocardium of patients with arrhythmogenic right ventricular cardiomyopathy","volume":"53","author":"Calabrese","year":"2000","journal-title":"J. Clin. Pathol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/eurheartj\/12.suppl_D.22","article-title":"Right ventricular cardiomyopathy: Is there evidence of an inflammatory aetiology?","volume":"12","author":"Thiene","year":"1991","journal-title":"Eur. Hear. J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/europace\/euaa343","article-title":"\u2018Hot phase\u2019 clinical presentation in arrhythmogenic cardiomyopathy","volume":"23","author":"Bariani","year":"2021","journal-title":"Europace"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1093\/eurheartj\/ehy567","article-title":"An autoantibody identifies arrhythmogenic right ventricular cardiomyopathy and participates in its pathogenesis","volume":"39","author":"Chatterjee","year":"2018","journal-title":"Eur. Hear. J."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1161\/CIRCULATIONAHA.119.043931","article-title":"Evidence From Family Studies for Autoimmunity in Arrhythmogenic Right Ventricular Cardiomyopathy","volume":"141","author":"Caforio","year":"2020","journal-title":"Circulation"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1136\/hrt.71.3.215","article-title":"Diagnosis of arrhythmogenic right ventricular dysplasia\/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology","volume":"71","author":"McKenna","year":"1994","journal-title":"Br. Heart. J."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1161\/CIRCULATIONAHA.108.840827","article-title":"Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy\/Dysplasia","volume":"121","author":"Marcus","year":"2010","journal-title":"Circulation"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.1016\/j.hrthm.2019.05.007","article-title":"2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy","volume":"16","author":"Towbin","year":"2019","journal-title":"Hear. Rhythm."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ijcard.2020.06.005","article-title":"Diagnosis of arrhythmogenic cardiomyopathy: The Padua criteria","volume":"319","author":"Corrado","year":"2020","journal-title":"Int. J. Cardiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2459\/JCM.0000000000000499","article-title":"Clinical recommendations of cardiac magnetic resonance, Part II","volume":"18","author":"Pontone","year":"2017","journal-title":"J. Cardiovasc. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.115.017944","article-title":"Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy\/Dysplasia","volume":"132","author":"Corrado","year":"2015","journal-title":"Circulation"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/CIRCGENETICS.113.000288","article-title":"Compound and Digenic Heterozygosity Predicts Lifetime Arrhythmic Outcome and Sudden Cardiac Death in Desmosomal Gene\u2013Related Arrhythmogenic Right Ventricular Cardiomyopathy","volume":"6","author":"Rigato","year":"2013","journal-title":"Circ. Cardiovasc. Genet."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1056\/NEJMra1509267","article-title":"Arrhythmogenic Right Ventricular Cardiomyopathy","volume":"376","author":"Corrado","year":"2017","journal-title":"New Engl. J. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/eurheartj\/ehz103","article-title":"A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy","volume":"40","author":"Bosman","year":"2019","journal-title":"Eur. Hear. J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e008509","DOI":"10.1161\/CIRCEP.120.008509","article-title":"Sudden Cardiac Death Prediction in Arrhythmogenic Right Ventricular Cardiomyo-pathy: A Multinational Collaboration","volume":"14","author":"Bosman","year":"2021","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1093\/cvr\/cvaa084","article-title":"Arrhythmogenic cardiomyopathy: Pathogenesis, pro-arrhythmic remodelling, and novel approaches for risk stratification and therapy","volume":"116","author":"Riele","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/eurheartj\/ehx011","article-title":"Sex hormones affect outcome in arrhythmogenic right ventricular cardiomyopathy\/dysplasia: From a stem cell derived cardiomyocyte-based model to clinical biomarkers of disease outcome","volume":"38","author":"Akdis","year":"2017","journal-title":"Eur. Hear. J."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1586\/14779072.2015.1053873","article-title":"Current applications of biomarkers in cardiomyopathies","volume":"13","author":"Coats","year":"2015","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/FJC.0b013e31821823d9","article-title":"Biomarkers of Myocardial Fibrosis","volume":"57","author":"Vos","year":"2011","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_51","first-page":"44","article-title":"Monitoring cardiac fibrosis: A technical challenge","volume":"20","year":"2011","journal-title":"Neth. Hear. J."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cca.2014.06.028","article-title":"Biomarkers of the extracellular matrix and of collagen fragments","volume":"443","author":"Chalikias","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1161\/01.RES.0000013290.12884.A3","article-title":"Matrix Metalloproteinases","volume":"90","author":"Spinale","year":"2002","journal-title":"Circ. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-05001-z","article-title":"MiR-320a as a Potential Novel Circulating Biomarker of Arrhythmogenic CardioMyopathy","volume":"7","author":"Sommariva","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"28101","DOI":"10.1038\/srep28101","article-title":"Profiling of differentially expressed microRNAs in arrhythmogenic right ventricular cardiomyopathy","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1161\/CIRCRESAHA.116.303549","article-title":"Long Noncoding RNAs and MicroRNAs in Cardiovascular Pathophysiology","volume":"116","author":"Thum","year":"2015","journal-title":"Circ. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/FJC.0b013e3181ee81df","article-title":"Regulation of Myocardial Fibrosis by MicroRNAs","volume":"56","author":"Bauersachs","year":"2010","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_58","first-page":"980","article-title":"MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts","volume":"456","author":"Thum","year":"2008","journal-title":"Nat. Cell Biol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/1354750X.2016.1278266","article-title":"Soluble ST2 is associated with disease severity in arrhythmogenic right ventricular cardiomyopathy","volume":"22","author":"Broch","year":"2017","journal-title":"Biomarkers"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.hrthm.2012.01.024","article-title":"Plasma BIN1 correlates with heart failure and predicts arrhythmia in patients with arrhythmogenic right ventricular cardiomyopathy","volume":"9","author":"Hong","year":"2012","journal-title":"Hear. Rhythm."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e003688","DOI":"10.1161\/CIRCEP.115.003688","article-title":"Characterizing the Molecular Pathology of Arrhythmogenic Cardiomyopathy in Patient Buccal Mucosa Cells","volume":"9","author":"Asimaki","year":"2016","journal-title":"Circ. Arrhythmia Electrophysiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0195-668X(03)00195-7","article-title":"The ajmaline challenge in Brugada syndrome: Diagnostic impact, safety, and recommended protocol","volume":"24","author":"Rolf","year":"2003","journal-title":"Eur. Hear. J."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/europace\/eun030","article-title":"Arrhythmogenic right ventricular dysplasia-cardiomyopathy and provocable coved-type ST-segment elevation in right precordial leads: Clues from long-term follow-up","volume":"10","author":"Peters","year":"2008","journal-title":"Europace"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s12471-011-0206-1","article-title":"Noninvasive detection of epicardial and endocardial activity of the heart","volume":"19","author":"Oostendorp","year":"2011","journal-title":"Neth. Hear. J."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.echo.2012.05.008","article-title":"Early Detection of Regional Functional Abnormalities in Asymptomatic ARVD\/C Gene Carriers","volume":"25","author":"Teske","year":"2012","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/europace\/euv340","article-title":"Arrhythmogenic right ventricular cardiomyopathy, clinical manifestations, and diagnosis","volume":"18","author":"Haugaa","year":"2015","journal-title":"Europace"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1056\/NEJMoa1915932","article-title":"Subcutaneous or Transvenous Defibrillator Therapy","volume":"383","author":"Knops","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ijcard.2019.01.041","article-title":"Subcutaneous implantable cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy: Results from an Italian multicenter registry","volume":"280","author":"Migliore","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jacc.2014.04.035","article-title":"Ventricular Arrhythmias in the North American Multidisciplinary Study of ARVC","volume":"64","author":"Link","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jacep.2016.10.014","article-title":"Subcutaneous Implantable Cardioverter-Defibrillator and Arrhythmogenic Right Ventricular Cardiomyopathy","volume":"3","author":"Migliore","year":"2017","journal-title":"JACC Clin. Electrophysiol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/jce.13894","article-title":"Multicentre experience with the second-generation subcutaneous implantable cardioverter defibrillator and the intermuscular two-incision implantation technique","volume":"30","author":"Migliore","year":"2019","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.hrthm.2018.05.011","article-title":"Prospective blinded evaluation of a novel sensing methodology designed to reduce inappropriate shocks by the subcutaneous implantable cardioverter-defibrillator","volume":"15","author":"Theuns","year":"2018","journal-title":"Hear. Rhythm."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","article-title":"2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"36","author":"Priori","year":"2015","journal-title":"Eur. Hear. J."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jacc.2011.09.051","article-title":"Cardiac Transplantation in Arrhythmogenic Right Ventricular Dysplasia\/Cardiomyopathy","volume":"59","author":"Tedford","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA Guideline for the Management of Heart Failure: A report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/ejhf.1139","article-title":"Effect of sacubitril\/valsartan on recurrent events in the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF)","volume":"20","author":"Mogensen","year":"2018","journal-title":"Eur. J. Hear. Fail."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"240ra74","DOI":"10.1126\/scitranslmed.3008008","article-title":"Identification of a New Modulator of the Intercalated Disc in a Zebrafish Model of Arrhythmogenic Cardiomyopathy","volume":"6","author":"Asimaki","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/jci.insight.85923","article-title":"Central role for GSK3\u03b2 in the pathogenesis of arrhythmogenic cardiomyopathy","volume":"1","author":"Chelko","year":"2016","journal-title":"JCI Insight"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1161\/CIRCULATIONAHA.119.040676","article-title":"Therapeutic Modulation of the Immune Response in Arrhythmogenic Cardiomyopathy","volume":"140","author":"Chelko","year":"2019","journal-title":"Circulation"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/FJC.0000000000000316","article-title":"Pentoxifylline Ameliorates Cardiac Fibrosis, Pathological Hypertrophy, and Cardiac Dysfunction in Angiotensin II-induced Hypertensive Rats","volume":"67","author":"Zhang","year":"2016","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s40119-018-0104-3","article-title":"A Review of Interleukin-1 in Heart Disease: Where Do We Stand Today?","volume":"7","author":"Szekely","year":"2018","journal-title":"Cardiol. Ther."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1093\/hmg\/dds265","article-title":"Abnormal p38 mitogen-activated protein kinase signaling in dilated cardiomyopathy caused by lamin A\/C gene mutation","volume":"21","author":"Muchir","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/CIRCEP.111.968677","article-title":"Outcomes of Catheter Ablation of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Dysplasia\/Cardiomyopathy","volume":"5","author":"Philips","year":"2012","journal-title":"Circ. Arrhythmia Electrophysiol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/CIRCULATIONAHA.108.834903","article-title":"Epicardial Substrate and Outcome with Epicardial Ablation of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Cardiomyopathy\/Dysplasia","volume":"120","author":"Garcia","year":"2009","journal-title":"Circulation"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.hrthm.2010.09.088","article-title":"Endocardial unipolar voltage mapping to identify epicardial substrate in arrhythmogenic right ventricular cardiomyopathy\/dysplasia","volume":"8","author":"Polin","year":"2011","journal-title":"Hear. Rhythm."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jacep.2018.09.019","article-title":"Outcomes of Catheter Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy Without Background Implantable Cardioverter Defibrillator Therapy","volume":"5","author":"Santangeli","year":"2019","journal-title":"JACC Clin. Electrophysiol."},{"key":"ref_89","first-page":"607","article-title":"Safety, long-term outcomes and predictors of recurrence after first-line combined endoepicardial ventricular tachycardia substrate ablation in arrhythmogenic cardiomyopathy. Impact of arrhythmic substrate distribution pattern. A prospective multicentre study","volume":"19","author":"Berruezo","year":"2016","journal-title":"Europace"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/13\/2750\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:21:24Z","timestamp":1760163684000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/13\/2750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,22]]},"references-count":89,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2021,7]]}},"alternative-id":["jcm10132750"],"URL":"https:\/\/doi.org\/10.3390\/jcm10132750","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,22]]}}}